BSMS > About BSMS > Contact us > Staff > Dr Sarah Partridge

Dr Sarah Partridge

Dr Sarah Partridge (PhD)

Research Fellow
E: S.Partridge@bsms.ac.uk
Location: Room 321, Watson Building, Falmer Campus, Brighton and Sussex Medical School, BN1 9PH

Areas of expertise: Epidemiology, Medical Writing, Clinical Trial Design, Hypertension

Research areas: Primary Care and Public Health, Cardiovascular Disease Prevention, Fibromyalgia, Clinical Trial Design

Other relevant positions: Member of the Guidelines and Information Working Party for the British and Irish Hypertension Society

Preferred gender pronouns: She/her

Biography

Sarah is an experienced medical writer and research fellow in the Department of Primary Care and Public Health. She is a member of the Guidelines and Information Working Party for the British and Irish Hypertension Society who work closely with NHS England and The National Institute for Health and Care Excellence (NICE). She has undertaken clinical and epidemiological studies in hypertension and HIV at Imperial College and Barts and The London Medical School. She has practical experience in primary care and the pharmaceutical industry.

Research

Sarah's research interests encompass a broad range of topics in primary care and public health and include hypertension, HIV, clinical trial design and implementation. She is interested in the barriers to accessing effective health and social care. She is currently working on a study investigating the efficacy of low dose naltrexone and pathophysiological mechanisms among patients with Fibromyalgia.

Teaching

Sarah is passionate about teaching medical students the art of writing. She currently teaches academic skills, inequalities and inclusion healthcare and a SSC on Medical Student Wellbeing.

Selected publications

McCormack T, Partridge S, Wilkinson IB. Specialist hypertension clinics: an essential pathway but under-resourced. British Journal of General Practice 2024; 74 (740): 100-102. https://doi.org/10.3399/bjgp24X736390

Lewis P, George J, Kapil V, Poulter NR, Partridge S, Goodman J, Faconti L, McCormack T, Wilkinson IB. Adult hypertension referral pathway and therapeutic management: British and Irish Hypertension Society position statement. J Hum Hypertension 2024;38:3–7. https://doi.org/10.1038/s41371-023-00882-2

Kulkarni S, Glover M, Kapil V, Abrams SML, Partridge S, McCormack T, Sever P, Delles C, Wilkinson IB. Management of hypertensive crisis: British and Irish Hypertension Society Position document. J Hum Hypertens 2023;37:863–879. https://doi.org/10.1038/s41371-022-00776-9

Partridge S, Quadt L, Bolton M, Eccles J, Thompson C, Colasanti A, Bremner S, Jones CI, Bruun KD, Van Marwijk H. A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. Heliyon 2023;9(5):e15638. doi: 10.1016/j.heliyon.2023.e15638.

Partridge S, Bolton M, Quadt L, Van Marwijk H. A systematic review of the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with Fibromyalgia. PROSPERO 2022 CRD42022312279 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022312279

Wilson S, Scullard G, Poulter NR. Association between HIV status, antiretroviral therapy and blood pressure. HIV Medicine 2009;10(6):388-94

Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, Poulter NR. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007;49:1-7

Wilson SL, Poulter NR. The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults. Journal of Hypertension 2006;24:1457-1469

Wilson S, Johnston A, Robson J, Poulter N, Collier D, Feder G, Caulfield M. Comparison of methods to identify individuals at increased risk of coronary disease from the general population. British Medical Journal 2003;326:1436-1438

Wilson S, Johnston A, Robson J, Poulter NR, Collier DJ, Feder GS, Caulfield MJ. Predicting coronary risk in the general population – is it necessary to measure high density lipoprotein cholesterol?. Journal of Cardiovascular Risk 2003;10(2):137-141